Chronic methamphetamine self‐administration dysregulates oxytocin plasma levels and oxytocin receptor fibre density in the nucleus accumbens core and …
The neuropeptide oxytocin attenuates reward and abuse for the psychostimulant
methamphetamine (METH). Recent findings have implicated the nucleus accumbens (NA c) …
methamphetamine (METH). Recent findings have implicated the nucleus accumbens (NA c) …
Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine‐seeking behaviour in rats
The psychostimulant methamphetamine (METH) is an addictive illicit drug. Systemic
administration of the neuropeptide oxytocin modulates METH‐related reward and METH …
administration of the neuropeptide oxytocin modulates METH‐related reward and METH …
[HTML][HTML] The involvement of oxytocin in the subthalamic nucleus on relapse to methamphetamine-seeking behaviour
The psychostimulant methamphetamine (METH) is an addictive drug of abuse. The
neuropeptide oxytocin has been shown to modulate METH-related reward and METH …
neuropeptide oxytocin has been shown to modulate METH-related reward and METH …
Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in …
Recent preclinical evidence indicates that the neuropeptide oxytocin may have potential in
the treatment of drug dependence and drug withdrawal. Oxytocin reduces …
the treatment of drug dependence and drug withdrawal. Oxytocin reduces …
Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core
Addiction to the psychostimulant Methamphetamine (METH) is characterised by high rates of
relapse. Currently there are no approved effective pharmacotherapies for METH …
relapse. Currently there are no approved effective pharmacotherapies for METH …
The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement
The neuropeptide oxytocin has shown promise as an effective therapy in pre-clinical models
of methamphetamine (METH) addiction. The nucleus accumbens core (NAcc) has been …
of methamphetamine (METH) addiction. The nucleus accumbens core (NAcc) has been …
Chronic methamphetamine treatment induces oxytocin receptor up-regulation in the amygdala and hypothalamus via an adenosine A2A receptor-independent …
P Zanos, SR Wright, P Georgiou, JH Yoo… - Pharmacology …, 2014 - Elsevier
There is mounting evidence that the neuropeptide oxytocin is a possible candidate for the
treatment of drug addiction. Oxytocin was shown to reduce methamphetamine self …
treatment of drug addiction. Oxytocin was shown to reduce methamphetamine self …
Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats
There is emerging evidence that the neuropeptide oxytocin may be utilised as a treatment
for various psychopathologies, including drug addictions. Here we used an animal model to …
for various psychopathologies, including drug addictions. Here we used an animal model to …
The neurocircuitry involved in oxytocin modulation of methamphetamine addiction
SJ Baracz, JL Cornish - Frontiers in neuroendocrinology, 2016 - Elsevier
The role of oxytocin in attenuating the abuse of licit and illicit drugs, including the
psychostimulant methamphetamine, has been examined with increased ferocity in recent …
psychostimulant methamphetamine, has been examined with increased ferocity in recent …
Oxytocin acts in nucleus accumbens to attenuate methamphetamine seeking and demand
Background Evidence indicates that oxytocin, an endogenous peptide well known for its role
in social behaviors, childbirth, and lactation, is a promising addiction pharmacotherapy. We …
in social behaviors, childbirth, and lactation, is a promising addiction pharmacotherapy. We …
相关搜索
- self administration subthalamic nucleus
- plasma levels subthalamic nucleus
- plasma levels self administration
- self administration behaviour in rats
- involvement of oxytocin subthalamic nucleus
- rostral nucleus oxytocin treatment
- up regulation oxytocin receptor
- amygdala and hypothalamus oxytocin receptor
- adenosine a2a oxytocin receptor
- oxytocinergic neurons subthalamic nucleus
- self administration dose response
- self administration dopamine levels